Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 3 | 2012 | 34 | 0.350 |
Why?
|
| Down Syndrome | 1 | 2002 | 15 | 0.180 |
Why?
|
| Hemodynamics | 2 | 2011 | 164 | 0.120 |
Why?
|
| Heart Bypass, Right | 1 | 2012 | 1 | 0.090 |
Why?
|
| Heart Septal Defects | 1 | 2011 | 1 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2012 | 146 | 0.090 |
Why?
|
| Fontan Procedure | 1 | 2011 | 3 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 27 | 0.090 |
Why?
|
| Pharyngeal Diseases | 1 | 2009 | 10 | 0.070 |
Why?
|
| Edema | 1 | 2009 | 29 | 0.070 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2009 | 10 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2012 | 666 | 0.070 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2003 | 11 | 0.050 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2003 | 8 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2003 | 74 | 0.050 |
Why?
|
| Atrioventricular Node | 1 | 2002 | 6 | 0.050 |
Why?
|
| Physical Examination | 1 | 2002 | 83 | 0.040 |
Why?
|
| Linear Models | 2 | 2012 | 426 | 0.040 |
Why?
|
| Length of Stay | 2 | 2012 | 321 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 650 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2012 | 1423 | 0.040 |
Why?
|
| Logistic Models | 2 | 2012 | 743 | 0.040 |
Why?
|
| Infant | 2 | 2012 | 1010 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2012 | 3408 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2002 | 624 | 0.030 |
Why?
|
| Humans | 6 | 2012 | 32262 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2011 | 1233 | 0.030 |
Why?
|
| Child | 2 | 2011 | 2430 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2011 | 1839 | 0.030 |
Why?
|
| Adolescent | 2 | 2011 | 3509 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 2238 | 0.020 |
Why?
|
| North America | 1 | 2012 | 31 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2012 | 33 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 98 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2011 | 8 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 2011 | 20 | 0.020 |
Why?
|
| Reoperation | 1 | 2012 | 247 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2011 | 58 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2011 | 52 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2012 | 197 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 141 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 566 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 272 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 79 | 0.020 |
Why?
|
| Heart Atria | 1 | 2011 | 81 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 190 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 772 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1178 | 0.020 |
Why?
|
| Lymphadenitis | 1 | 2009 | 4 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2009 | 24 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 59 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2009 | 53 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 99 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 2203 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 1478 | 0.020 |
Why?
|
| Male | 3 | 2011 | 19429 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 3933 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 904 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2003 | 12 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2003 | 44 | 0.010 |
Why?
|
| Ligation | 1 | 2003 | 64 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 892 | 0.010 |
Why?
|
| Female | 2 | 2011 | 19935 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2003 | 818 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 3609 | 0.010 |
Why?
|